HC
BMY icon

Hurley Capital’s Bristol-Myers Squibb BMY Stock Holding History

Hurley Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14K Buy
124
+8
+7% +$459 ﹤0.01% 369
2026
Q1 		$7.04K Sell
116
-107
-48% -$6.24K ﹤0.01% 368
2025
Q4 		$12K Buy
223
+97
+77% +$4.67K 0.01% 308
2025
Q3 		$5.68K Buy
126
+10
+9% +$467 ﹤0.01% 426
2025
Q2 		$5.37K Hold
116
– – ﹤0.01% 363
2025
Q1 		$7.08K Hold
116
– – 0.01% 355
2024
Q4 		$7.13K Buy
+116
New +$6.48K 0.01% 314

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hurley Capital's BMY Position: Q2 2026 in Review

Hurley Capital increased its Bristol-Myers Squibb (BMY) stake by 6.9% in Q2 2026, buying an estimated $459 and bringing the position to 124 shares worth $7.14K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Hurley Capital first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $12K in Q4 2025. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Hurley Capital held 124 shares of Bristol-Myers Squibb worth $7.14K as of Q2 2026.
  • Hurley Capital bought 8 Bristol-Myers Squibb shares in Q2 2026, an estimated $459.
  • Bristol-Myers Squibb made up ﹤0.01% of Hurley Capital's portfolio in Q2 2026, its #369 holding.
  • Hurley Capital first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
  • Hurley Capital's Bristol-Myers Squibb position peaked at $12K in Q4 2025.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hurley Capital's 13F filing for Q2 2026, filed 10 Aug 2026.